Literature DB >> 1354842

Comparison of glutamine synthetases from brains of genetically epilepsy prone and genetically epilepsy resistant rats.

G F Carl1, L A Thompson, J T Williams, V C Wallace, B B Gallagher.   

Abstract

Since glutamine synthetase (GS) has been proposed as the primary enzyme in the regulation of glutamate metabolism in the central nervous system and since inhibition of the activity of this enzyme in vivo leads to seizures, it has been proposed that an abnormality in the structure or function of this enzyme could be responsible for the induction of seizures in epilepsy prone rats. To test this hypothesis the glutamine synthetases were purified from the brains of both genetically epilepsy prone rats (GEPR) and their progenitors, genetically epilepsy resistant rats (GERR). The enzymes were compared using both SDS-PAGE and isoelectric focusing. The immunoreactivities of equal amounts of protein were determined using the ELISA technique, and the regulation of the glutamine synthetase activities by Mn2+/Mg2+ ratios were compared. The only difference found between the glutamine synthetases from the two strains was a slightly lower specific activity of the enzyme from the epilepsy prone animals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354842     DOI: 10.1007/bf00966830

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  17 in total

1.  Influence of manganese on susceptibility of rats to convulsions.

Authors:  L S HURLEY; D E WOOLLEY; F ROSENTHAL; P S TIMIRAS
Journal:  Am J Physiol       Date:  1963-03

2.  Studies on the mechanism of glutamine synthesis; isolation and properties of the enzyme from sheep brain.

Authors:  V PAMILJANS; P R KRISHNASWAMY; G DUMVILLE; A MEISTER
Journal:  Biochemistry       Date:  1962-01       Impact factor: 3.162

3.  Isolation and characterization of the rat glutamine synthetase-encoding gene.

Authors:  L van de Zande; W T Labruyère; A C Arnberg; R H Wilson; A J van den Bogaert; A T Das; D A van Oorschot; C Frijters; R Charles; A F Moorman
Journal:  Gene       Date:  1990-03-15       Impact factor: 3.688

4.  Rat liver glutamine synthetase. Preparation, properties, and mechanism of inhibition by carbamyl phosphate.

Authors:  S S Tate; F Y Leu; A Meister
Journal:  J Biol Chem       Date:  1972-09-10       Impact factor: 5.157

5.  Glutamine synthetase from mammalian tissues.

Authors:  A Meister
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

6.  Association of low blood manganese concentrations with epilepsy.

Authors:  G F Carl; C L Keen; B B Gallagher; M S Clegg; W H Littleton; D B Flannery; L S Hurley
Journal:  Neurology       Date:  1986-12       Impact factor: 9.910

7.  Manganese and epilepsy: brain glutamine synthetase and liver arginase activities in genetically epilepsy prone and chronically seizured rats.

Authors:  G F Carl; L K Blackwell; F C Barnett; L A Thompson; C J Rissinger; K L Olin; J W Critchfield; C L Keen; B B Gallagher
Journal:  Epilepsia       Date:  1993 May-Jun       Impact factor: 5.864

8.  Reciprocal regulation of glutamine synthetase and carbamoylphosphate synthetase levels in rat liver.

Authors:  C J de Groot; G H ten Voorde; R E van Andel; A te Kortschot; J W Gaasbeek Janzen; R H Wilson; A F Moorman; R Charles; W H Lamers
Journal:  Biochim Biophys Acta       Date:  1987-04-29

9.  Chick brain glutamine synthetase and Mn2+-Mg2+ interactions.

Authors:  G Tholey; S Bloch; M Ledig; P Mandel; F Wedler
Journal:  Neurochem Res       Date:  1987-11       Impact factor: 3.996

10.  Concentrations of physiologically important metal ions in glial cells cultured from chick cerebral cortex.

Authors:  G Tholey; M Ledig; P Mandel; L Sargentini; A H Frivold; M Leroy; A A Grippo; F C Wedler
Journal:  Neurochem Res       Date:  1988-01       Impact factor: 3.996

View more
  1 in total

1.  Disturbances of amino acids from temporal lobe synaptosomes in human complex partial epilepsy.

Authors:  D M Labiner; C C Yan; M E Weinand; R J Huxtable
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.